Coromandel International Limited provides agriculture solutions in India and internationally. It operates through Nutrient and Other Allied Business, and Crop Protection segments. The company's crop nutrients comprises fertilizer, which includes complex, urea, potash muriate, Di-ammonium phosphate, and single superphosphate; specialty nutrients, such as crop specific water and generic water soluble grades, Sulphur based fertilizers, and micronutrients; and organic fertilizers. It also offers crop protection products including insecticide, herbicide, fungicide, bio-products, and plant growth regulators. In addition, the company operates through rural retail outlets, which provides soil testing, crop diagnostics, and farm mechanization services across Andhra Pradesh, Telangana, and Karnataka. The company was formerly known as Coromandel Fertilisers Ltd and changed its name to Coromandel International Limited in September 2009. Coromandel International Limited was incorporated in 1961 and is headquartered in Chennai, India. Coromandel International Limited is a subsidiary of E.I.D.-Parry (India) Limited.
Revenue projections:
Revenue projections for COROMANDEL COROMANDEL's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.
Financial Ratios:
currentRatio
0.000000
forwardPE
29.647652
debtToEquity
5.670000
earningsGrowth
1.217000
revenueGrowth
0.269000
grossMargins
0.249520
operatingMargins
0.093870
trailingEps
55.830000
forwardEps
56.630000
With COROMANDEL's Forward PE in a favorable range, the stock appears reasonably priced compared to its earnings. This suggests that it's not overpriced and there is room for growth, providing an encouraging opportunity for investors seeking future value increases. With both earnings and revenue growth showing positive trends, COROMANDEL is expected to expand its business. This signals a healthy financial trajectory, suggesting that the company is positioned for continued growth and increasing profitability. COROMANDEL's forward EPS surpasses its trailing EPS, indicating that the company is expected to be more profitable in the current financial year. This reflects growing confidence in COROMANDEL's earnings potential, suggesting stronger financial performance compared to the previous year.
Price projections:
Price projections for COROMANDEL
Recommendation changes over time:
Recommendations trend for COROMANDEL
Analysts have maintained a buy bias for COROMANDEL, which could prompt investors to consider the stock as a viable investment. With this positive outlook, COROMANDEL is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article examines the recent slowdown in GDP growth to 5.4 percent,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.